Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about SLC6A4: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
SLC6A4 is a protein involved in neurodegeneration research. Key relationships include: associated with, transports, expressed in. Associated with ALS, ALZHEIMER, ALZHEIMER'S. Connected to 158 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | SLC6A4 (SERT, 5HTT) |
| Aliases | Serotonin Transporter |
| Chromosome | 17q11.2 |
| Function | is a membrane protein that mediates the reuptake of serotonin (5-hydroxytryptamine, 5-HT) from the synaptic cleft back into presynaptic neurons. |
| Molecular Weight | 63 kDa |
| Amino Acids | 630 aa |
| Exons | 14 |
| Pathways | Apoptosis, Epigenetic, Mapk, autophagy pathway |
| UniProt ID | P31645 |
| NCBI Gene ID | 6532 |
| Ensembl ID | ENSG00000108576 |
| Associated Diseases | Addiction, Als, Alzheimer, Alzheimer's disease |
| Interactions | Actin, ALZHEIMER, ALZHEIMER'S DISEASE, AND, APOE, APOPTOSIS |
| KG Connections | 328 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
SLC6A4["SLC6A4 / SERT"] -->|"Reuptakes"| Serotonin["Serotonin / 5-HT"]
Serotonin -->|"Modulates"| Mood["Mood Regulation"]
SLC6A4 -->|"Polymorphisms affect"| Anxiety["Anxiety Disorders"]
SLC6A4 -->|"Polymorphisms affect"| Depression["Major Depression"]
SLC6A4 -->|"Associates with"| APOE["APOE Risk Factor"]
SLC6A4 -->|"Interacts with"| CYP3A4["CYP3A4 Metabolism"]
SLC6A4 -->|"Epigenetic via"| Methylation["DNA Methylation"]
SLC6A4 -->|"Cross-reacts"| ADRB2["ADRB2 Adrenergic"]
SLC6A4 -.Drug target.-> SSRIs["SSRIs / Antidepressants"]
SLC6A4 -.Associated with.-> Dementia["Dementia Risk"]
SLC6A4 -.Linked to.-> Alzheimer["Alzheimer's Disease"]| Target | Relation | Type | Str |
|---|---|---|---|
| Serotonin Reuptake | mediates | process | 0.95 |
| SUD | associated_with | disease | 0.72 |
| STING | activates | gene | 0.70 |
| TNF | regulates | gene | 0.70 |
| ALS | activates | disease | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Dementia | interacts_with | disease | 0.65 |
| Neurodegeneration | therapeutic_target | disease | 0.65 |
| Inflammation | associated_with | disease | 0.65 |
| Lymphoma | activates | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Addiction | associated_with | disease | 0.65 |
| Parkinson | activates | disease | 0.65 |
| Dementia | associated_with | disease | 0.65 |
| Dementia | therapeutic_target | disease | 0.65 |
| Depression | therapeutic_target | disease | 0.65 |
| Parkinson | protects_against | disease | 0.65 |
| Alzheimer | activates | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| ALS | associated_with | disease | 0.65 |
| Opioid | associated_with | disease | 0.65 |
| Depression | associated_with | disease | 0.65 |
| Als | expressed_in | disease | 0.65 |
| Als | protects_against | disease | 0.65 |
| Neurodegeneration | associated_with | disease | 0.65 |
| Anxiety | associated_with | disease | 0.65 |
| DRD4 | associated_with | gene | 0.60 |
| BDNF | associated_with | gene | 0.60 |
| SLC6A2 | associated_with | gene | 0.60 |
| FOXP2 | associated_with | gene | 0.60 |
| DRD2 | associated_with | gene | 0.60 |
| HTR2C | associated_with | gene | 0.60 |
| LRRK2 | associated_with | gene | 0.60 |
| FKBP5 | expressed_in | gene | 0.60 |
| NDEL1 | expressed_in | gene | 0.60 |
| SLC30A8 | associated_with | gene | 0.60 |
| GCH1 | expressed_in | gene | 0.60 |
| DISC1 | expressed_in | gene | 0.60 |
| KCNK2 | associated_with | gene | 0.60 |
| GCH1 | associated_with | gene | 0.60 |
| CYP3A4 | associated_with | gene | 0.60 |
| NUCKS1 | transports | gene | 0.60 |
| CYP2D6 | associated_with | gene | 0.60 |
| BDNF | expressed_in | gene | 0.60 |
| CYP2D6 | transports | gene | 0.60 |
| SLC6A2 | transports | gene | 0.60 |
| CHRNA5 | associated_with | gene | 0.60 |
| BCHE | associated_with | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| HTR2A | regulates | gene | 0.70 |
| ACHE | targets | gene | 0.70 |
| CHOLINERGIC | regulates | cell_type | 0.70 |
| HTR2A | transports | gene | 0.70 |
| CHRNA7 | targets | gene | 0.70 |
| DOPAMINERGIC | regulates | cell_type | 0.70 |
| GABAERGIC | regulates | cell_type | 0.70 |
| HSP90 | regulates | gene | 0.70 |
| GENES | therapeutic_target | gene | 0.60 |
| DEPRESSION | associated_with | gene | 0.60 |
| PER | interacts_with | gene | 0.60 |
| CYP2E1 | associated_with | gene | 0.60 |
| ALZHEIMER | associated_with | gene | 0.60 |
| ALZHEIMER'S DISEASE | associated_with | gene | 0.60 |
| ANXIETY | associated_with | gene | 0.60 |
| GENES | interacts_with | gene | 0.60 |
| GENES | transports | gene | 0.60 |
| PARKINSON'S DISEASE | activates | gene | 0.60 |
| PARKINSON | activates | gene | 0.60 |
| MAPK | activates | gene | 0.60 |
| ALZHEIMER | activates | gene | 0.60 |
| AND | activates | gene | 0.60 |
| SKA2 | associated_with | gene | 0.60 |
| DNA | associated_with | gene | 0.60 |
| ITGB1 | associated_with | gene | 0.60 |
| NEURODEGENERATION | associated_with | gene | 0.60 |
| INFLAMMATION | associated_with | gene | 0.60 |
| GENES | expressed_in | gene | 0.60 |
| DNA | expressed_in | gene | 0.60 |
| LRRK2 | transports | gene | 0.60 |
| NUCKS1 | transports | gene | 0.60 |
| CYP2D6 | transports | gene | 0.60 |
| SLC6A2 | transports | gene | 0.60 |
| SNCA | transports | gene | 0.60 |
| GCH1 | transports | gene | 0.60 |
| DRD2 | transports | gene | 0.60 |
| SLC6A3 | transports | gene | 0.60 |
| CYP1A2 | associated_with | gene | 0.60 |
| APOE | transports | gene | 0.60 |
| ABCB1 | transports | gene | 0.60 |
| CYP3A4 | transports | gene | 0.60 |
| AKT1 | targets | gene | 0.60 |
| GABRA2 | associated_with | gene | 0.60 |
| MAOA | associated_with | gene | 0.60 |
| BDNF | activates | gene | 0.60 |
| MTHFR | associated_with | gene | 0.60 |
| AD | co_discussed | gene | 0.60 |
| NEUROINFLAMMATION | regulates | pathway | 0.60 |
| OXIDATIVE STRESS | co_discussed | pathway | 0.60 |
| APOE | targets | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning SLC6A4 in their description or question text
No additional research found